Introduction

Neuroscience is undergoing a major resurgence. After more than a decade of limited successes and cautious investment by most big pharma, a new era innovation is unfolding. Driven by a confluence of factors – the vast unmet need (a 2021 Lancet Neurology study found 3.4 billion people worldwide suffer from nervous system disorders), and the dedication of patients, scientists, physicians, regulators, and companies have continued to de-risk the space with continued innovation on multiple fronts. We explore the latest advancements poised to reshape the future of neurosciences 2024 and beyond.

Major advances are occurring in multiple fronts
  1. Better understanding of disease biology/improved models
  2. Continued elucidation of targets and approaches to address
  3. Optimized clinical trial design/better endpoints
  4. More flexible regulatory structure that understands the significant need for new therapeutics

Read the full article now

"*" indicates required fields

Sign me up to receive regular insights from Lumanity
By selecting this box, I consent to receive Lumanity marketing communications by email.
This field is for validation purposes and should be left unchanged.